MedPath

Nutrition Throughout the Treatment Course - Expanding Care From Hospital to Home

Not Applicable
Active, not recruiting
Conditions
Head and Neck Cancer
Registration Number
NCT05997329
Lead Sponsor
University of Oslo
Brief Summary

Patients with cancer have increased risk of malnutrition due to the disease itself and the treatment regimen they undergo. This is particularly relevant for patients with head and neck cancer (HNC), where 74%-95% are malnourished. HNC is a heterogenous group of cancers, including oral cavity, larynx, pharynx and salivary glands. The present project will study the effectiveness and implementation of remote patient monitoring of nutrition and tailored nutrition support throughout the treatment course in patients with head and neck cancer. The implementation will be evaluated in a randomized controlled trial (RCT), and the aim of the project is to reduce the prevalence of malnutrition and increase the quality of life among patients with HNC.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
125
Inclusion Criteria
  • Head and neck cancer
  • Older than 18 years
Exclusion Criteria
  • Patients admitted with the classification of malignant tumors (TNM) stage 4
  • Terminal condition (life expectancy < 6 months)
  • Patients who do not understand the Norwegian language.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Malnutrition_PGSGA18 weeks

Measured by the: Patient-Generated Subjective Global Assessment (PG-SGA). The tool categories participants into: category A (Well-nourished), B (Moderately malnutrition or possible malnutrition), or C (serious malnutrition)

Secondary Outcome Measures
NameTimeMethod
Malnutrition GLIM18 weeks

Malnutrition measured by the objective method developed by the Global Leadership Initiative on Malnutrition (GLIM). The GLIM-criteria also categories the participants i three groups: Well-nourished, moderate malnutrition and severe malnutrition.

Nutrition intake18 weeks

24-hour recall interviews

Health-related quality of life18 weeks

EuroQol Research Foundation, Netherlands (EQ5D-5L). Assess health in 5 dimensions each of which has three response levels (1: No problems, 2: some problems and 3: extreme problems/unable to do).

Number of Participants compliant to the intervention18 weeks

Review of reported use of the MyFood app in the electronic patient record

Number of patients with non-elective readmissions18 weeks

Review of readmissions in the electronic patient record

Weight change18 weeks

weight measurements

Body composition18 weeks

Bioelectrical Impedance Analysis (BIA)

Trial Locations

Locations (2)

University of Oslo

🇳🇴

Oslo, Oslo County, Norway

Oslo University Hospital

🇳🇴

Oslo, Norway

University of Oslo
🇳🇴Oslo, Oslo County, Norway
Christine Henriksen, PhD
Contact
+4799003128
christine.henriksen@medisin.uio.no

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.